Return on Innovation: An Eight-Part Series

cro_thumnail_2.jpg

Harris-Williams Bio-Crop 0067 1421 PaulHepper

Managing Director

Profile

Harris-Williams Bio-Crop 0040 JulianFeneley 1

Harris-Williams Bio-Crop 0021 089 DanLinsalata

Harris-Williams Bio-Crop 0003 AndreyDvorkin

Director

Harris Williams advised Velocity Clinical Research (Velocity), a portfolio company of NaviMed Capital, on its sale to Global Healthcare Opportunities, or GHO Capital Partners LLP. Velocity is a leading integrated site organization for clinical trials.

Velocity Clinical Research

United States

5203-velocity-clinical-research.png

Mergers & Acquisitions

Harris Williams advised Kantar Health, a division of Kantar and portfolio company of Bain Capital Private Equity, on its sale to Cerner Corporation (NASDAQ: CERN ) . Kantar Health is a leading global healthcare data, analytics and research provider.

Kantar Health

4992kantar-health.png

Harris Williams advised Altasciences, a portfolio company of Audax Private Equity, on its sale to Novo Holdings. Founded in 1992, Altasciences is a fully integrated, early drug development services platform, providing the pharma and biotech industries with a trusted partner for drug development, from preclinical safety testing through to clinical proof-of-concept studies.

Altasciences

Canada

altasciences-project-helix.png

An analytics-driven commercialization solutions provider for biopharmaceutical customers 
 
 A portfolio company of Windrose Health Investors 
 
 Has been recapitalized by Court Square Capital Partners

Medical Knowledge Group

medical-knowledge-group-2.png

Site Map

Privacy

Terms Of Use

Cookie Policy

Disclosures

We are a global investment bank specializing in M&A and private capital advisory services. Clients worldwide rely on us to help unlock value in their business and turn ambitious goals into reality.

About Us

Our Capabilities

We have eight dedicated Industry Groups led by senior professionals who have deep knowledge and experience across sectors, service offerings, and geographies.

Our Industries

Access our latest insights on evolving industry dynamics and marketplace trends.

Our Insights

Our momentum as a firm is strong. We carry this momentum forward by hiring people who are smart, driven, and principled. If you are a team player who thrives on collaborating with colleagues and clients, we invite you to learn more about our career opportunities. 

Careers

Contact Us

Experienced Bankers

Analysts

Associates

Search for People, Insights, Transactions...

Return on Innovation, Part 1: Commercialization Services

hcls_image_1.jpg

Return on Innovation, Part 2: Contract Research Organizations

cro_thumbnail.jpg

Return on Innovation, Part 3: Pharmaceutical Safety and Risk Management

srm_thumbnail.jpg

Return on Innovation, Part 4: Contract Development and Manufacturing Organizations (CDMOs)

gettyimages-1135377743.jpg

Return on Innovation, Part 5: Real-World Evidence

gettyimages-713768495.jpg

Return on Innovation, Part 6: Clinical Trial Sites

GettyImages-998296772

Return on Innovation, Part 7: Outsourced Pharma Services: Differentiating Via Data

Outsourced Pharma Services: Differentiating Via Data

Return on Innovation, Part 8: Investing in Drug Discovery

Outsourced Pharma Services Drug Discovery Stock

Select Activity